Live Breaking News & Updates on Michaelj Labarre

Stay updated with breaking news from Michaelj labarre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Torray Investment Partners LLC

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Torray Investment Partners LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Michaelj Labarre , Bessemer Group Inc , Halozyme Therapeutics Inc , Halozyme Therapeutics Company Profile , Covestor Ltd , Montaga Associates Inc , Torray Investment Partners , Massmutual Trust Co , Tower Group , Goldman Sachs Group , Exchange Commission , Halozyme Therapeutics , Free Report , Investment Partners , Therapeutics Trading Down , Get Free Report , Visit Holdingschannel , Halozyme Therapeutics Daily ,

Q2 2024 EPS Estimates for Halozyme Therapeutics, Inc. Decreased by Analyst (NASDAQ:HALO)

Q2 2024 EPS Estimates for Halozyme Therapeutics, Inc. Decreased by Analyst (NASDAQ:HALO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Michaelj Labarre , Goldman Sachs Group , Marshall Wace , Thrivent Financial For Lutherans , Norges Bank , Zacks Research , Macquarie Group Ltd , Halozyme Therapeutics Inc , Morgan Stanley , Allspring Global Investments Holdings , Halozyme Therapeutics , Free Report , Halozyme Therapeutic , Get Free Report , Global Investments Holdings , Halozyme Therapeutics Daily ,

Fox Run Management L.L.C. Invests $669,000 in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Fox Run Management L.L.C. bought a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 17,510 shares of the biopharmaceutical company’s stock, valued at approximately $669,000. A number of other large investors […] ....

United States , Michaelj Labarre , Vanguard Group Inc , Artisan Partners Limited Partnership , Halozyme Therapeutics Inc , Geode Capital Management , Goldman Sachs Group , Securities Exchange Commission , Macquarie Group Ltd , Morgan Stanley , Halozyme Therapeutics , Free Report , Partners Limited Partnership , Capital Management , Get Free Report , Visit Holdingschannel , Halozyme Therapeutics Daily , Nasdaq Halo , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,